Companion animal periodontal disease is one of the most prevalent diseases seen by veterinarians. The goal of this study was to evaluate the vaccine performance of a trivalent canine periodontitis vaccine in the mouse oral challenge model of periodontitis. Mice vaccinated subcutaneously with an inactivated, whole-cell vaccine preparation of Porphyromonas denticanis, Porphyromonas gulae, and Porphyromonas salivosa displayed significantly reduced alveolar bone loss in response to heterologous and cross-species challenges as compared to sham vaccinated animals. Based on the results of these studies, a periodontitis vaccine may be a useful tool in preventing the initiation and progression of periodontitis caused by the most commonly isolated pigmenting anaerobic bacteria in animals.
Get full access to this article
View all access options for this article.
References
1.
HarveyCEEmilyPP. Hyperplastic gingivitis. In: HarveyCEEmilyPP, editors. Small animal dentistry. St. Louis, MO, Mosby-Year Books, 1993: 89–144.
2.
PenmanS.HarveyCE. Periodontal disease. In: HarveyCEOrrHS, editors. Manual of small animal dentistry. Cheltenham, BSAVA, 1990: 37–39.
3.
HennetPRHarveyCE. Natural development of periodontal disease in the dog: A review of clinical, anatomical and histological features. J Vet Dent1992; 9:13–19.
4.
CutlerCWKalmarJRGencoCA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol1995; 3:45–51.
5.
LamontRJJenkinsonHF. Life below the gum line: Pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev1998; 62:1244–1263.
6.
PageRCHoustonLS. Prospects for vaccination against plaque-related oral diseases. Dental plaque revisited. London, BioLine, 1999: 563–585.
7.
PageRC. Vaccination and periodontitis: Myth or reality. J Int Acad Periodontol2000; 2:31–43.
8.
AllakerRPde RosayroR. Prevalence of Porphyromonas and Prevotella species in the dental plaque of dogs. Vet Rec1997; 140:147–148.
9.
BoyceENChingRJ. Occurrence of gram-negative black-pigmented anaerobes in subgingival plaque during the development of canine periodontal disease. Clin Infect Dis1995;20Suppl 2:S317–S319.
10.
ForsblomBLoveDN. Characterization of anaerobic, gram-negative, nonpigmented, saccharolytic rods from subgingival sites in dogs. Clin Infect Dis1997; 25Suppl 2:S100–S106.
11.
HarveyCEThornsberryCMillerBR. Subgingival bacteria–comparison of culture results in dogs and cats with gingivitis. J Vet Dent1995; 12:147–150.
12.
HarveyCE. Periodontal disease in dogs. Etiopathogenesis, prevalence, and significance. Vet Clin North Am Small Anim Pract1998; 28:1111–1128.
13.
HennetPRHarveyCE. Anaerobes in periodontal disease in the dog: A review. J Vet Dent1991;8:18–21.
14.
IsogaiHKosakoY. Ecology of genus Porphyromonas in canine periodontal disease. J Vet Med1999; 46:467–473.
15.
DreyerWPBassonNJ. Porphyromonas gingivalis as putative pathogen in ovine periodontitis. J Dental Assoc S Africa1992; 47:513–516.
16.
FournierDMoutonC. Porphyromonas gulae sp. nov., an anaerobic, Gram-negative coccobacillus from the gingival sulcus of various animal hosts. Int J Syst Evol Microbiol2001; 51:1179–1189.
HardhamJDreierK. Pigmented-anaerobic bacteria associated with canine periodontitis. Vet Microbiol2005; 106:119–128.
19.
HardhamJReedM. Evaluation of a monovalent companion animal periodontal disease vaccine in an experimental mouse periodontitis model. Vaccine2005; 23: 3148–3156.
20.
BakerPJEvansRTRoopenianDC. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol1994; 39:1035–1040.
21.
DeBowesLJ. The effects of dental disease on systemic disease. Vet Clin North Am Small Anim Pract1998; 28:1057–1062.
22.
DeCarloAAHuangY. Feasibility of an HA2 domain-based periodontitis vaccine. Infect Immun2003;71:562–566.
23.
EbersoleJLBrunsvoldM. Effects of immunization with Porphyromonas gingivalis and Prevotella intermedia on progression of ligature-induced periodontitis in the nonhuman primate Macaca fascicularis. Infect Immun1991; 59:3351–3359.
24.
EvansRTKlausenBGencoRJ. Immunization with fimbrial protein and peptide protects against Porphyromonas gingivalis-induced periodontal tissue destruction. Adv Exp Med Biol1992; 327:255–262.
25.
GibsonFCIIIGencoCA. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with Gingipain R1. Infect Immun2001; 69:7959–7963.
26.
GonzalezDTzianabosAO. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun2003; 71:2283–2287.
27.
NakagawaTSaitoA. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine. Keio J Med2003; 52:158–162.
28.
NamikoshiJOtakeS. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis. Vaccine2003; 22:250–256.
29.
PerssonGREngelD. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun1994; 62:1026–1031.
30.
RobertsFAHoustonLS. Periodontitis vaccine decreases local prostaglandin E2 levels in a primate model. Infect Immun2004; 72:1166–1168.
31.
RossBCCzajkowskiL. Characterization of two outer membrane protein antigens of Porphyromonas gingivalis that are protective in a murine lesion model. Oral Micro Immun2004;19:6–15.
32.
ZhangPYangQ. Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systematic responses to recombinant HagB from Porphyromonas gingivalis. Vaccine2003; 21:4459–4471.
33.
VaselDSimsTJ. Shared antigens on Porphyromonas gingivalis and Bacteroides forsythus. Oral Microbiol Immunol1996; 11:226–235.
34.
Unpublished Pfizer Internal data, study number 3860R-60-03-198.
35.
AwanoSGoharaK. The relationship between the presence of periodonto-pathogenic bacteria in saliva and halitosis. Int Dent J2002; 52Suppl 3:212–216.
36.
KostelcJGZelsonPR. Quantitative differences in volatiles from healthy mouths and mouths with periodontitis. Clin Chem1981; 27:842–845.
37.
NakanoYYoshimuraMKogaT. Correlation between oral malodor and periodontal bacteria. Microbes Infect2002; 4:679–683.
38.
DaveSBatistaELJrVan DykeTE. Cardiovascular disease and periodontal diseases: Commonality and causation. Compend Contin Educ Dent2004; 25:26–37.
39.
DeBowesLJMosierD. Association of periodontal disease and histologic lesions in multiple organs from 45 dogs. J Vet Dent1996; 13:57–60.
40.
LoosBG. Systemic markers of inflammation in periodontitis. J Periodontol2005; 76: 2106–2115.
41.
PaquetteDW. The periodontal-cardiovascular link. Compend Contin Educ Dent2004; 25:681–692.
42.
LamontRJJenkinsonHF. Life below the gum line: Pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev1998; 62:1244–1263.
43.
YangEYTannerAC. Periodontal pathogen detection in gingival/tooth and tongue flora samples from 18–48 month-old children and periodontal status of their mothers. Oral Microbiol Immunol2002; 17:55–59.
44.
SocranskySSHaffajeeAD. Microbial complexes in subgingival plaque. J Clin Periodontol1998; 25:134–144.
45.
CutlerCWKalmarJRGencoCA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol1995; 3:45–51.
46.
GencoCAPotempaJ. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin Inf Dis1999; 28:456–465.
